Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00871832 · ClinicalTrials.gov registry record

Pre-admission Hyperglycemia and Its Effect on Morbidity and Mortality

A clinical trial of Hyperglycemia, sponsored by Northwell Health.

Completed
Registry status
200
Enrollment target
1
Study location

NCT00871832 is a study of Hyperglycemia that has completed, run by Northwell Health. The registered enrollment target is 200 participants, below the 874-participant average among 38 other Hyperglycemia trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00871832, a study of Hyperglycemia, has completed, sponsored by Northwell Health.

COMPLETED
Registry status
200 participants
Enrollment target
1
Study location

Study Summary

It is currently standard of care in many Medical and Surgical ICU's to institute a nurse driven insulin protocol in maintaining tight glucose control in the critical patient. Many articles have been written to address this topic. However, there is no current data regarding the use of glycohemoglobin as a marker of risk of morbidity and mortality. In our study we would like to determine whether or not the HbA1C could be used as a marker of morbidity and mortality. The HbA1C is a simple blood test that may be added on to any CBC collection tube; a blood sample that critical patients have drawn up to several times a day. The investigators would analyze this information in respect to the rest of the clinical data collected regarding the patient's illness.

Conditions Studied

Study Locations (1)

New York

  • Staten Island University Hospital - Staten Island

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2007-05
Est. Completion 2010-03

Sponsor

Northwell Health

370 total trials

What the Registry Record Tells You About NCT00871832

The ClinicalTrials.gov registry entry for NCT00871832 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 874-participant average among 38 other Hyperglycemia trials with a reported enrollment target (77% lower). The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hyperglycemia appearing as the primary indexed condition, and to 0 interventions.

NCT00871832 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT00871832 about?

NCT00871832 is a clinical study titled "Pre-admission Hyperglycemia and Its Effect on Morbidity and Mortality". It is currently standard of care in many Medical and Surgical ICU's to institute a nurse driven insulin protocol in maintaining tight glucose control in the critical patient. Many articles have been written to address this topic. However, there is no current data regarding the use of glycohemoglobin...

What is the current status of trial NCT00871832?

This trial is currently completed. The enrollment target is 200 participants. The study started on 2007-05. Estimated completion is 2010-03.

What conditions does trial NCT00871832 study?

This clinical trial studies the following conditions: Hyperglycemia.

Who is sponsoring clinical trial NCT00871832?

This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00871832 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hyperglycemia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.